Fiche du document
1998
- doi: 10.1074/jbc.273.20.12203
- issn: 0021-9258
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1074/jbc.273.20.12203
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/9575168
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0021-9258
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5FF43594B66A7
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Genetic transductionCiter ce document
K. Burns et al., « MyD88, an adapter protein involved in interleukin-1 signaling. », Serveur académique Lausannois, ID : 10.1074/jbc.273.20.12203
Métriques
Partage / Export
Résumé
MyD88 has a modular organization, an N-terminal death domain (DD) related to the cytoplasmic signaling domains found in many members of the tumor necrosis factor receptor (TNF-R) superfamily, and a C-terminal Toll domain similar to that found in the expanding family of Toll/interleukin-1-like receptors (IL-1R). This dual domain structure, together with the following observations, supports a role for MyD88 as an adapter in IL-1 signal transduction; MyD88 forms homodimers in vivo through DD-DD and Toll-Toll interactions. Overexpression of MyD88 induces activation of the c-Jun N-terminal kinase (JNK) and the transcription factor NF-kappaB through its DD. A point mutation in MyD88, MyD88-lpr (F56N), which prevents dimerization of the DD, also blocks induction of these activities. MyD88-induced NF-kappaB activation is inhibited by the dominant negative versions of TRAF6 and IRAK, which also inhibit IL-1-induced NF-kappaB activation. Overexpression of MyD88-lpr or MyD88-Toll (expressing only the Toll domain) acted to inhibit IL-1-induced NF-kappaB and JNK activation in a 293 cell line overexpressing the IL-1RI. MyD88 coimmunoprecipitates with the IL-1R signaling complex in an IL-1-dependent manner.
